# Cartography Biosciences

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cartography-biosciences

- Industry: Biotechnology
- Headquarters: San Carlos, US
- Website: www.cartography.bio
- Total disclosed funding: $130M
- Latest round: Series B (Oct 2, 2025)
- Investors on record: 15

## About

Based in California, US, and founded in 2020 by its CEO Kevin Parker, and co-founders Howard Chang, and Ansu Satpathy, Cartography Biosciences, Inc. operates as a therapeutics company that provides medicine for immuno-oncology and cancers. In May 2026, Cartography Biosciences, Inc. raised venture funding from Samsung Venture Investment.

Cartography Biosciences, Inc. offers a platform that integrates cutting-edge computational and experimental techniques, including single-cell genomics and proteomics to create immunotherapies by identifying the targets that maximize efficacy, and analyze cancers while minimizing potentially toxic side effects.

## Funding rounds

- Series B, Oct 2, 2025, $67M — Amgen Ventures, ARTIS Ventures, Andreessen Horowitz, Pfizer Venture Investments, AME Cloud Ventures, Wing, 8VC, Gaingels, Catalio Capital Management, LG Corp, Global BioAccess Fund, Finchley Healthcare Ventures, Lotte Holdings CVC
- Series A, Jul 19, 2022, $57M — Alexandria Venture Investments, ARTIS Ventures, Andreessen Horowitz, AME Cloud Ventures, Wing, 8VC, Gaingels, Catalio Capital Management, Cancer Research Institute
- Seed, Oct 23, 2020, $6M — Andreessen Horowitz, Wing

## Investors

- Andreessen Horowitz (https://capitalatlas.ai/funds/andreessen-horowitz) — Seed, Series A, Series B
- Wing (https://capitalatlas.ai/funds/wing) — Seed, Series A, Series B
- Alexandria Venture Investments (https://capitalatlas.ai/funds/alexandria-venture-investments) — Series A
- ARTIS Ventures (https://capitalatlas.ai/funds/artis-ventures) — Series A, Series B
- AME Cloud Ventures (https://capitalatlas.ai/funds/ame-cloud-ventures) — Series A, Series B
- 8VC (https://capitalatlas.ai/funds/8vc) — Series A, Series B
- Gaingels (https://capitalatlas.ai/funds/gaingels) — Series A, Series B
- Catalio Capital Management (https://capitalatlas.ai/funds/catalio-capital-management) — Series A, Series B
- Cancer Research Institute — Series A
- Amgen Ventures (https://capitalatlas.ai/funds/amgen-ventures) — Series B
- Pfizer Venture Investments (https://capitalatlas.ai/funds/pfizer-venture-investments) — Series B
- LG Corp — Series B
- Global BioAccess Fund (https://capitalatlas.ai/funds/global-bioaccess-fund) — Series B
- Finchley Healthcare Ventures (https://capitalatlas.ai/funds/finchley-healthcare-ventures) — Series B
- Lotte Holdings CVC — Series B